
08/07/2025
Janus kinase (JAK) inhibitors are small molecule medications that can affect multiple inflammatory cytokines. The oral JAK inhibitors tofacitinib and upadacitinib are used to treat ulcerative colitis, and upadacitinib is also used for Crohn's disease. To learn more about the role of JAK inhibitors for the management of IBD, and the role of the pharmacist in supporting patients, enrol in the complimentary, CCCEP-accredited, online course entitled Practical Pharmacist Strategies for Managing IBD with JAK Inhibitors.
Enrol now: https://healthelearning.ca/ #/curricula/83fd6204-5b3d-49e6-a6e7-a0a63123e4a7